INGR Form 4: SVP David Seip allocated phantom stock based on $122.12 close
Rhea-AI Filing Summary
Ingredion Inc (INGR) reporting person: David Eric Seip, SVP, Global Ops and CSCO, acquired phantom stock under the company's SERP on 09/30/2025. The Form 4 shows a transaction coded A (acquisition) for Phantom Stock with a reported unit amount of 9.097 and an attributed price of $122.12. The filing lists 9,100.5431 shares as the amount of common stock beneficially owned following the reported transaction. The explanatory note states these figures represent the aggregate number of phantom stock shares allocated based on the closing price of Ingredion common stock on September 30, 2025, and that each phantom stock unit represents the right to receive one share of common stock.
Positive
- Compensatory grant disclosed: The Form 4 clearly reports a SERP-based phantom stock allocation on 09/30/2025, satisfying Section 16 reporting requirements
- Full explanatory note included: Filing explains calculation basis (closing price) and that each unit represents the right to receive one share
Negative
- None.
Insights
TL;DR: Insider received phantom stock units as executive compensation; the transaction is compensatory and not a market sale.
The Form 4 discloses a compensatory allocation under the SERP on 09/30/2025 to an executive officer. The disclosed unit amount (9.097) and the attached per-share price ($122.12) are presented alongside a stated beneficial ownership total of 9,100.5431 shares following the allocation. This is a routine, non-cash equity-linked award that increases the reporting person's exposure to the company's stock price without an immediate open-market purchase or sale. There are no indications of disposition or trading that would signal liquidity events or insider selling pressure.
TL;DR: Disclosure is standard for SERP-based phantom stock grants; documentation appears complete for Section 16 reporting.
The filing contains the required details: reporting person identity and role, transaction date (09/30/2025), transaction code (A), and a narrative explaining the nature of the grant. The signature block is present and dated 10/01/2025 by an attorney-in-fact. From a compliance perspective, the Form 4 provides the essential facts for investor and regulator review of insider compensation. The entry describes rights to future common shares via phantom units rather than immediate share issuance.
FAQ
What insider transaction did David Eric Seip report on Form 4 for INGR?
How many phantom stock units were recorded in the Form 4 for INGR?
What price was used to calculate the phantom stock allocation on the INGR Form 4?
Does the Form 4 indicate an actual sale or open-market purchase of Ingredion shares?
Who signed the Form 4 for the reporting person and when?